匹兹堡大学医学中心Jeremy Rich教授团队在Cell Metabolism杂志上发表了题为Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2的论文。

Six main cell types form glioblastomas (GBM), the most aggressive brain cancer due to its high rate of recurrence. Of these six, quiescent cancer stem cells are responsible for resistance to therapy ...

As she investigates cancer treatments and pursues her own path toward becoming a physician-scientist, the Brown University ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

These targets were identified through a screen for genetic vulnerabilities in patient-derived cancer stem cells that represent the variability found in tumours. Glioblastoma is the most common ...

A new study identifies key genetic vulnerabilities in glioblastoma stem cells, revealing subtype-specific dependencies that ...

Gliocidin selectively kills glioblastoma cells by inhibiting nucleotide synthesis, showing potential as a therapeutic option ...

Aug. 12, 2024 — Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro ...

Researchers at the Joint Department of Biomedical Engineering at UNC and North Carolina State University recently received a $3.15 million grant from the National Cancer Institute.

Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku >Immunotherapy, which enhances the ...